Eli Lilly pauses trial of coronavirus antibody drug over safety concern October 14, 2020August 8, 2022 Coronaheadsup.com Coronavirus, Health, Science https://uk.reuters.com/article/us-health-coronavirus-eli-lilly/eli-lilly-pauses-trial-of-antibody-drug-trump-touted-as-covid-19-cure-over-safety-concern-idUSKBN26Y2TE ** This post was originally published on October 14, 2020 **Share this:Post Related Posts: Growth advantage for BQ.1.1 is above 100% per weekStudy: Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccineUSA: Florida recommends against males aged 18 to 39 receiving mRNA COVID-19 vaccinesMultiple hypermutated SARS-CoV-2 sequences that may have been created by molnupiravirLong Covid: Petition calls on Germany to expedite BC007 clinical trialsVaccine Watch - a compilation of press reports and studies regarding Covid-19 vaccine…